Evidence map›Paper›PMID 32205351›Full record

ArticleAntimicrobial agents and chemotherapy2020

Reconciling the Potentially Irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in

Timothy J Davies, Nicole Stoesser, Anna E Sheppard, Manal Abuoun, Philip Fowler, Jeremy Swann, T Phuong Quan, David Griffiths, Alison Vaughan, Marcus Morgan and 12 more

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Beyond the Spotlight:Antibiotics (Basel, Switzerland) · 2025
    Review
  6. Article
  7. Article
  8. Observational
  9. Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  10. Genomic epidemiology of third-generation cephalosporin-resistantApplied and environmental microbiology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 2 countries.

Timothy J DaviesNuffield Department of Medicine, Oxford University, Oxford, United Kingdom timothy.davies@ndm.ox.ac.uk.
Nicole StoesserNuffield Department of Medicine, Oxford University, Oxford, United Kingdom.ORCID 0000-0002-4508-7969
Anna E SheppardNuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
Manal AbuounBacteriology, Animal and Plant Health Agency, Surrey, United Kingdom.
Philip FowlerNuffield Department of Medicine, Oxford University, Oxford, United Kingdom.ORCID 0000-0003-0912-4483
Jeremy SwannNuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
T Phuong QuanNuffield Department of Medicine, Oxford University, Oxford, United Kingdom.ORCID 0000-0001-8566-1817
David GriffithsNuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
Alison VaughanNuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
Marcus MorganOxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Hang T T PhanNuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
Katie J JefferyOxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Monique AnderssonOxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Matt J EllingtonAntimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, United Kingdom.
Oskar EkelundDepartment of Clinical Microbiology and the EUCAST Development Laboratory, Kronoberg Region, Central Hospital, Växjö, Sweden.
Neil WoodfordNational Institute for Health Research Health Protection Research Unit on Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, United Kingdom.
Amy J MathersDivision of Infectious Diseases and International Health, Department of Medicine, Clinical Microbiology, Department of Pathology, University of Virginia Health System, Charlottesville, Virginia, USA.ORCID 0000-0002-3533-6351
Robert A BonomoLouis Stokes Cleveland Veterans Affairs Medical Centre, Research Service, Cleveland, Ohio, USA.
Derrick W CrookNuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
Tim E A PetoNuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
Muna F AnjumBacteriology, Animal and Plant Health Agency, Surrey, United Kingdom.
A Sarah WalkerNuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
National Institute for Health Research · GBUniversity of Oxford · GBOxford University Hospitals NHS Trust · GBAnimal and Plant Health Agency · GBPublic Health England · GBGeriatric Research Education and Clinical Center · USUniversity of Virginia Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resistance to amoxicillin-clavulanate, a widely used beta-lactam/beta-lactamase inhibitor combination antibiotic, is rising globally, and yet susceptibility testing remains challenging. To test whether whole-genome sequencing (WGS) could provide a more reliable assessment of susceptibility than traditional methods, we predicted resistance from WGS for 976

Indexed as

Amoxicillin-Potassium Clavulanate CombinationEscherichia coliAnti-Bacterial Agentsbeta-LactamasesClavulanic AcidMicrobial Sensitivity TestsPhenotypeUnited KingdomAmoxicillin-Potassium Clavulanate CombinationAnti-Bacterial Agentsbeta-LactamasesClavulanic Acidantibiotic resistanceantimicrobial combinationsbeta-lactamase inhibitormicrobial genomicssusceptibility testing

Identifiers

PMID32205351
PMCPMC7269502
OpenAlexW3011584473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.